Medicare Enrolled

Dr. Joseph Berger, MD, RPH

Psychiatry · Atlanta, GA
Speaking/Promotional
1 DUNWOODY PARK, Atlanta, GA 30338
7707308912
In practice since 2006 (19 years)
NPI: 1164526117 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Berger from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Berger? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Berger

Dr. Joseph Berger is a psychiatry specialist in Atlanta, GA, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Berger received a total of $49,638 from 25 pharmaceutical and/or device companies across 229 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in psychiatry. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Berger is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice $49,638 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$49,638
Total received (2018-2024)
Avg $7,091/year across 7 years
Top 4% in GA for psychiatry
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
25
Companies
229
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$43,875 (88.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,247 (10.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$516 (1.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$944
2023
$1,650
2022
$895
2021
$1,860
2020
$2,036
2019
$15,958
2018
$26,295

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$226
Tris Pharma Inc
$157
Vanda Pharmaceuticals Inc.
$131
Otsuka America Pharmaceutical, Inc.
$127
Janssen Pharmaceuticals, Inc
$126
Axsome Therapeutics, Inc.
$94
TG Therapeutics, Inc.
$69
Almatica Pharma LLC
$15
Top 3 companies account for 54.5% of 2024 payments
All-time payments by company (2018-2024) ›
Shire North American Group Inc
$25,548
Ironshore Pharmaceuticals Inc.
$9,899
Takeda Pharmaceuticals U.S.A., Inc.
$8,727
Janssen Pharmaceuticals, Inc
$1,492
Otsuka America Pharmaceutical, Inc.
$546
Axsome Therapeutics, Inc.
$459
Corium, LLC
$384
ITI, Inc.
$374
Lundbeck LLC
$341
Tris Pharma Inc
$282
Indivior Inc.
$250
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$226
Vanda Pharmaceuticals Inc.
$190
Alkermes, Inc.
$130
Teva Pharmaceuticals USA, Inc.
$129
ViiV Healthcare Company
$116
AbbVie Inc.
$109
Neurocrine Biosciences, Inc.
$107
Supernus Pharmaceuticals, Inc.
$104
EISAI INC.
$95
TG Therapeutics, Inc.
$69
Adlon Therapeutics L.P.
$19
Noven Therapeutics, LLC
$16
Almatica Pharma LLC
$15
Bausch Health US, LLC
$13
Top 3 companies account for 89.0% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ADHANSIA XR · AUSTEDO · AZSTARYS · Auvelity · Azstarys · BRINTELLIX · BRIUMVI · CAPLYTA · Dayvigo · Dyanavel XR · Entyvio · FANAPT · HETLIOZ · INGREZZA · INVEGA SUSTENNA · Jornay PM 20mg capsules (Bottle of 100) · LOREEV XR · LYBALVI · MYDAYIS · QELBREE · Quillichew ER · REXULTI · RUKOBIA · SPRAVATO · SUBOXONE SUBLINGUAL FILM · TRINTELLIX · Trintellix · VRAYLAR · VYVANSE · Vyvanse · WELLBUTRIN · Xelstrym
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (88%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in psychiatry and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for psychiatry in GA.

Looking for a psychiatry specialist in Atlanta?
Compare psychiatrists in the Atlanta area by procedure volume, costs, and industry payment transparency.
Browse psychiatrists nearby

Geographic Context

Psychiatrists within 10 mi
633
Per 100K population
83.1
County median income
$77,683
Nearest hospital
PEACHFORD BEHAVIORAL HEALTH SYSTEM OF ATLANTA
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Berger is a psychiatry specialist, with speaking/promotional industry engagement in the top 4% of GA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Berger receive payments from pharmaceutical companies?
Yes. Dr. Berger received a total of $49,638 from 25 companies across 229 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Berger) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →